genentech

Welcome to the 'genentech' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'genentech'.

Latest blogosphere posts tagged “genentech”

• Costly new drugs: A crisis for one family, a quandry for U.S.

  
  The Platform — Authority: 567
  Dan Callahan It began with a little black spot on Dan Callahan’s lower lip. He didn’t think it was anything to worry about. His doctor thought it was cancer. The doctor was right. It was neurotropic melanoma, a very rare — and very…
  4 days ago

• iRise User Group – San Francisco Meeting Highlights

  
  The iRise Blog — Authority: 108
  With a beautiful view of the San Francisco Bay as a backdrop, iRise users met yesterday to hear case studies from other users and compare notes on driving adoption of visualization for software projects.  Highlights from the meeting… Marty Chuck – Keynote Presentation Marty Chuck delivered a keynote ...
  1 week ago

• CMS Blinks Over Avastin Medicare Coding

  
  Pharmalot — Authority: 589
  After pressure from Congress and concern from doctors, the Centers for Medicare and Medicaid now plans to reverse recently enacted reimbursement coding for Avastin, which is used to treat wet macular degeneration, a leading cause of blindness among seniors and the elderly. The drug, you may recall, is often used ...
  1 week ago

• Medicare reverses billing change on Genentech drug

  
  Health Fitness & Beauty - health-fitness.marc8.com — Authority: 158
  WASHINGTON (AP) -- Medicare officials are backing off a policy that pushed many doctors to use a $2,000 injectable drug for a potentially blinding eye disorder, over a similar treatment that costs about $50....
  1 week ago

• Additional PML Brain Infection Cases Linked to Tysabri and Rituxan

  
  AboutLawsuits.com — Authority: 552
  New cases of a rare brain infection, progressive multifocal leukoencephalopathy (PML) , have been liked to the lymphoma and arthritis drug Rituxan and the multiple sclerosis (MS) drug Tysabri . The cases have regulators in the U.S. and Europe searching for ways to reduce the risks of patients developing the often ...
  2 weeks ago

• Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029

  
  Xconomy — Authority: 712
  Biotech , people , Life Sciences Luke Timmerman wrote: Seattle has more than its share of brilliant biologists for a medium-sized American city. But if people and ideas are going to properly mix to create a thriving local biotech industry over the next two decades, we could use a few more common places ...
  3 weeks ago

• Positive Rheumatoid Arthritis Data for UCB, Trubion, Others

  
  OneMedPlace — Authority: 122
  Data presented this weekend at the American College of Rheumatology ’s annual meeting indicated that rheumatoid arthritis patients who adhered to a prescription drug regimen had better medical outcomes and lower medical costs, Reuters reports . The study looked at the medical  and pharmacy claims of RA patients ...
  3 weeks ago

• FDA nixes wider use of rheumatoid arthritis drug

  
  Business Finance & Economy - business.marc8.com — Authority: 163
  The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday.
  3 weeks ago

• Science Magazine Survey: American Life Sciences Companies are Some of the Best to Work for in the World

  
  Bio Job Blog — Authority: 469
  An annual survey conducted by Science magazine and the American Association has identified the 2008 top twenty life sciences employers in the world. The rankings were based on a company’s leadership, stability, social responsibility and treatment of its employees. Six of the top 10— Genentech, Gilead Sciences, ...
  3 weeks ago

• Flu drug Tamiflu boosts Roche sales in Q3

  
  Survival News Network — Authority: 143
  Roche (ROG.VX) beat forecasts with a 10 percent rise in third-quarter sales, helped by demand for Tamiflu due to the H1N1 swine flu pandemic, and the Swiss group now sees higher drug revenues for the full year.Tamiflu outstripped expectations in the third quarter and Roche, the world’s largest maker of cancer drugs ...
  3 weeks ago

• Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News

  
  Xconomy — Authority: 712
  Roundup , Biotech , cancer Luke Timmerman wrote: The news has been breaking fast and furious here at Xconomy, just as we are putting the finishing touches on a terrific event on Monday that will explore the 20-year outlook for the Seattle region as a life sciences hub. —Xconomy dug up an exclusive ...
  3 weeks ago

• Flu drug Tamiflu boosts Roche sales in Q3

  
  Get Out of Dodge! — Authority: 135
  Roche (ROG.VX) beat forecasts with a 10 percent rise in third-quarter sales, helped by demand for Tamiflu due to the H1N1 swine flu pandemic, and the Swiss group now sees higher drug revenues for the full year. Tamiflu outstripped expectations in the third quarter and Roche, the world’s largest maker of cancer ...
  3 weeks ago

• This is the Agency that is Going to Bend the Cost Curve?

  
  John Goodman's Health Policy Blog — Authority: 564
  Writing in the New York Times , Andrew Pollack reports that Medicare is about to stop paying for Avastin as a treatment for eye diseases. He writes, “But the way the bureaucratic gears mesh in this case, the move could end up costing Medicare itself hundreds of millions of dollars a year, and individual patients ...
  4 weeks ago

• Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney

  
  Xconomy — Authority: 712
  Biotech , people , startups Luke Timmerman wrote: Investing in biotech can be scary. Only one out of 10 new drug candidates ever makes it through the gauntlet of clinical trials to become an FDA approved product, and it usually takes hundreds of millions of dollars and a decade or more of research to ...
  4 weeks ago

• Roche Cutting More Jobs at its Genentech Division

  
  Bio Job Blog — Authority: 469
  According to a report yesterday, Roche is reducing headcount at San Francisco-based Genentech by merging the information technology departments of its pharmaceutical and diagnostics divisions. The company didn’t disclose how many people would be losing jobs as a result of the consolidation. The company previously ...
  4 weeks ago

• Board Member Resignation Leaves Apple and Google Un-entwined

  
  ModCool — Authority: 455
  While the U.S Federal Trade Commission (FTC) is busy probing “the Google/Apple interlocking directorates issue” the two companies are trying their best to placate the trade regulator. A couple of months after Google CEO Eric Schmidt resigned from Apple’s board of directors, the last surviving link between the ...
  4 weeks ago

• Seattle Genetics Adds Marketing Boss

  
  Xconomy — Authority: 712
  Biotech , people , cancer Luke Timmerman wrote: Seattle Genetics, the Bothell, WA-based developer of targeted antibody drugs for cancer, said today it has hired its first head of commercial operations to prepare for the introduction of what it hopes will be its first marketed product. The company ...
  4 weeks ago

• Good ridance Arthur Levinson

  
  Trends Updates — Authority: 611
  Google ’s big boss spoke good about Arthur Levinson and about Apple recently, but there wasn’t another way: the CEO of Genentech , that worked until last week in the managements of two of the largest companies of the valley of the Silicon, had to leave giant of searches, something that was made official today ...
  4 weeks ago

• Roche To Give Genentech Employees More Options

  
  Pharmalot — Authority: 589
  In a bid to maintain the Genentech culture, Roche plans to reward the biotech’s employees with more long-term stock options than the folks who work for the big drug maker. Severin Schwan, Roche’s ceo, says that reviewing Genentech pay is a top priority and wants to keep things “entrepreneurial” at Genentech, ...
  4 weeks ago

• Levinson Leaves Google Board Amid F.T.C. Inquiry

  
  DealBook — Authority: 783
  Google said Monday that Arthur D. Levinson, the former chief executive of Genentech, is leaving its board of directors.
  4 weeks ago

Comments about genentech